Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$77 Hold
4
﹤0.01% 729
2022
Q1
$97 Sell
4
-23,300
-100% -$574K ﹤0.01% 992
2021
Q4
$614K Buy
23,304
+23,192
+20,707% +$612K 0.15% 152
2021
Q3
$2.86K Sell
112
-33,950
-100% -$838K ﹤0.01% 775
2021
Q2
$797K Buy
34,062
+33,950
+30,313% +$871K 0.18% 106
2021
Q1
$2.69K Hold
112
﹤0.01% 659
2020
Q4
$2.37K Sell
112
-1,382
-93% -$33.1K ﹤0.01% 612
2020
Q3
$37.2K Hold
1,494
0.01% 390
2020
Q2
$41.8K Sell
1,494
-4,326
-74% -$131K 0.01% 366
2020
Q1
$186K Sell
5,820
-4,297
-42% -$161K 0.05% 208
2019
Q4
$432K Buy
+10,117
New +$406K 0.08% 185

Other funds holding ECHO

Exane Derivatives's ECHO Position: Q2 2022 in Review

Exane Derivatives held its EchoStar (ECHO) position steady in Q2 2022 at 4 shares worth $77. The position accounts for ﹤0.01% of the portfolio, ranked #729.

Exane Derivatives first reported a position in ECHO in Q4 2019 and has held it in 11 quarters since. The position peaked at $797K in Q2 2021. 195 funds tracked by Wall St. Rank hold ECHO as of Q2 2022.

  • Exane Derivatives held 4 shares of EchoStar worth $77 as of Q2 2022.
  • Exane Derivatives left its EchoStar share count unchanged in Q2 2022.
  • EchoStar made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #729 holding.
  • Exane Derivatives first reported a position in EchoStar in Q4 2019 and has held it in 11 quarters since.
  • Exane Derivatives's EchoStar position peaked at $797K in Q2 2021.
  • 195 funds tracked by Wall St. Rank held EchoStar as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.